PD-L1 expression as a prognostic marker in patients treated with chemotherapy for metastatic non-small-cell lung cancer
Year: 2022
Type: article
Study designs: Systematic Review, Meta-Analysis
Source: Future Oncology
Institutions: The University of Sydney, St George Hospital, National Health and Medical Research Council, Royal Prince Alfred Hospital, Chris O’Brien Lifehouse, NSW Health Pathology, Western Sydney University, Prince of Wales Hospital, Peter MacCallum Cancer Centre, National Taiwan University Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4213123236